Abstract
Developing smart scaffolds with drug release capability is one of the main approaches to bone tissue engineering. The current study involves the fabrication of novel gelatin (G)–hydroxyapatite (HA)-/vitamin D (VD)-loaded graphene oxide (GO) scaffolds with different concentrations through solvent-casting method. Characterizations confirmed the successful synthesis of HA and GO, and VD was loaded in GO with 36.87 ± 4.87% encapsulation efficiency. Physicochemical characterizations showed that the scaffold containing 1% VD-loaded GO had the best mechanical properties and its porosity percentage and density was in the range of natural spongy bone. All scaffolds were degraded after 1-month, subjecting to phosphate buffer saline. The release profile of VD did not match any mathematical kinetics model, porosities and the degradation rate of the scaffolds were dominant controlling factors of release behavior. Studies on the bioactivity of scaffolds immersed in simulated body fluid indicated that VD and HA could encourage the formation of secondary apatite crystals in vitro. Buccal fat pad-derived stem cells (BFPSCs) were seeded on the scaffolds, MTT assay, alkaline phosphatase activity as an indicator of osteoconductivity, and cell adhesion were conducted in order to evaluate in vitro biological responses. All scaffolds highly supported cell adhesion, MTT assay indicated better cell viability in 0.5% VD-loaded GO containing scaffold, and the scaffold enriched with 2% VD-loaded GO performed the most ALP activity. The results demonstrated the potential of these scaffolds to induce bone regeneration.
Similar content being viewed by others
References
Woodruff MA, Lange C, Reichert J, Berner A, Chen F, Fratzl P, et al. Bone tissue engineering: from bench to bedside. Mater Today. 2012;15:430–5. https://doi.org/10.1016/S1369-7021(12)70194-3.
Wattanutchariya W, Changkowchai W. Characterization of porous scaffold from chitosan-gelatin/hydroxyapatite for bone grafting. Lect Notes Eng Comput Sci. 2210 (2014).
Henkel J, Woodruff MA, Epari DR, Steck R, Glatt V, Dickinson IC, et al. Bone regeneration based on tissue engineering conceptions—a 21st century perspective. Bone Res. 2013;1:216–48. https://doi.org/10.4248/BR201303002.
Rezwan K, Chen QZ, Blaker JJ, Boccaccini AR. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials. 2006;27:3413–31. https://doi.org/10.1016/j.biomaterials.2006.01.039.
Nezhadi SH, Choong PFM, Lotfipour F, Dass CR. Gelatin-based delivery systems for cancer gene therapy cancer gene therapy. J Drug Target. 2009;17:731–8. https://doi.org/10.3109/10611860903096540.
Chuenjitkuntaworn B, Inrung W, Damrongsri D, Mekaapiruk K, Supaphol P, Pavasant P. Polycaprolactone/hydroxyapatite composite scaffolds: preparation, characterization, and in vitro and in vivo biological responses of human primary bone cells. J Biomed Mater Res A. 2010;94:241–51. https://doi.org/10.1002/jbm.a.32657.
Moradi E, Ebrahimian-Hosseinabadi M, Khodaei M, Toghyani S. Magnesium/nano-hydroxyapatite porous biodegradable composite for biomedical applications. Mater Res Express. 2019;6:75408. https://doi.org/10.1088/2053-1591/ab187f.
Viswanath B, Ravishankar N. Controlled synthesis of plate-shaped hydroxyapatite and implications for the morphology of the apatite phase in bone. Biomaterials. 2008;29:4855–63. https://doi.org/10.1016/j.biomaterials.2008.09.001.
Ruegsegger P, Elsasser U, Anliker M, Gnehm H, Kind H, Prader A. Quantification of bone mineralization using computed tomography. Radiology. 1976;121:93–7. https://doi.org/10.1148/121.1.93.
Chang MC, Ko CC, Douglas WH. Preparation of hydroxyapatite-gelatin nanocomposite. Biomaterials. 2003;24:2853–62. https://doi.org/10.1016/S0142-9612(03)00115-7.
Azami M, Tavakol S, Samadikuchaksaraei A, Hashjin MS, Baheiraei N, Kamali M, et al. A porous hydroxyapatite/gelatin nanocomposite scaffold for bone tissue repair: In vitro and in vivo evaluation. J Biomater Sci Polym Ed. 2012;23:2353–68. https://doi.org/10.1163/156856211X617713.
Compton OC, Nguyen ST. Graphene oxide, highly reduced graphene oxide, and graphene: versatile building blocks for carbon-based materials. Small. 2010;6:711–23. https://doi.org/10.1002/smll.200901934.
Dubey N, Bentini R, Islam I, Cao T, Neto AHCastro, Rosa V. Graphene: a versatile carbon-based material for bone tissue engineering. Stem Cells Int. 2015;2015:18–23. https://doi.org/10.1155/2015/804213.
Shin SR, Li YC, Jang HL, Khoshakhlagh P, Akbari M, Nasajpour A, et al. Graphene-based materials for tissue engineering. Adv Drug Deliv Rev. 2016;105:255–74. https://doi.org/10.1016/j.addr.2016.03.007.
Feng L, Liu Z. Graphene in biomedicine: opportunities and challenges. Nanomedicine. 2011;6:317–24. https://doi.org/10.2217/nnm.10.158.
Bao H, Pan Y, Ping Y, Sahoo NG, Wu T, Li L, et al. Chitosan-functionalized graphene oxide as a nanocarrier for drug and gene delivery. Small. 2011;7:1569–78. https://doi.org/10.1002/smll.201100191.
Van Driel M, Van JPTM. Leeuwen, vitamin D endocrine system and osteoblasts. Bonekey Rep. 2014;3:1–8. https://doi.org/10.1038/bonekey.2013.227.
Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G. Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects. Physiological reviews. 2016;96(1):365–408. https://doi.org/10.1152/physrev.00014.2015.
Oku Y, Tanabe R, Nakaoka K, Yamada A, Noda S, Hoshino A, et al. Influences of dietary vitamin D restriction on bone strength, body composition and muscle in rats fed a high-fat diet: involvement of mRNA expression of MyoD in skeletal muscle. J Nutr Biochem. 2016;32:85–90. https://doi.org/10.1016/j.jnutbio.2016.01.013.
Rodríguez M, Daniels B, Gunawardene S, Robbins GK. High frequency of vitamin D deficiency in ambulatory HIV-Positive patients. AIDS Res Hum Retrovir. 2009;25:9–14. https://doi.org/10.1089/aid.2008.0183.
Azami M, Moztarzadeh F, Tahriri M. Preparation, characterization and mechanical properties of controlled porous gelatin/hydroxyapatite nanocomposite through layer solvent casting combined with freeze-drying and lamination techniques. J Porous Mater. 2010;17:313–20. https://doi.org/10.1007/s10934-009-9294-3.
Imani R, Emami SH, Faghihi S. Nano-graphene oxide carboxylation for efficient bioconjugation applications: a quantitative optimization approach. J Nanopart Res. 2015;17:1–15. https://doi.org/10.1007/s11051-015-2888-6.
Li H, Chang J. Preparation and characterization of bioactive and biodegradable Wollastonite/poly(D,L-lactic acid) composite scaffolds. J Mater Sci Mater Med. 2004;15:1089–95. https://doi.org/10.1023/B:JMSM.0000046390.09540.c2.
Kokubo T, Takadama H. How useful is SBF in predicting in vivo bone bioactivity? Biomaterials. 2006;27:2907–15. https://doi.org/10.1016/j.biomaterials.2006.01.017.
Murugan R, Ramakrishna S. Crystallographic study of hydroxyapatite bioceramics derived from various sources. Cryst Growth Des. 2005;5:111–2. https://doi.org/10.1021/cg034227s.
lósarczyk A, Paszkiewicz Z, Paluszkiewicz C. FTIR and XRD evaluation of carbonated hydroxyapatite powders synthesized by wet methods. J Mol Struct. 2005;7:657–61. https://doi.org/10.1016/j.molstruc.2004.11.078.
Liu J, Cui L, Losic D. Graphene and graphene oxide as new nanocarriers for drug delivery applications. Acta Biomater. 2013;9:9243–57. https://doi.org/10.1016/j.actbio.2013.08.016.
Mohammadi S, Shafiei SS, Asadi-Eydivand M, Ardeshir M, Solati-Hashjin M. Graphene oxide-enriched poly(ϵ-caprolactone) electrospun nanocomposite scaffold for bone tissue engineering applications. J Bioact Compat Polym. 2017;32:325–42. https://doi.org/10.1177/0883911516668666.
Wan C, Frydrych M, Chen B. Strong and bioactive gelatin-graphene oxide nanocomposites. Soft Matter. 2011;7:6159–66. https://doi.org/10.1039/c1sm05321c.
Fayyazbakhsh F, Solati-Hashjin M, Keshtkar A, Shokrgozar MA, Dehghan MM, Larijani B. Release behavior and signaling effect of vitamin D3 in layered double hydroxides-hydroxyapatite/gelatin bone tissue engineering scaffold: an in vitro evaluation. Colloids Surf B Biointerfaces. 2017;158:697–708. https://doi.org/10.1016/j.colsurfb.2017.07.004.
Narbat MK, Orang F, Hashtjin MS, Goudarzi A. Fabrication of porous hydroxyapatite-gelatin composite scaffolds for bone tissue engineering. Iran Biomed J. 2006;10:215–23.
Beauchamp RO, Clair MB, Fennell TR, Clarke DO, Morgan KT, Kair FW. A critical review of the toxicology of glutaraldehyde. Gastroenterol Nurs. 1993;16:42–3. https://doi.org/10.1097/00001610-199308000-00018.
Xiong G, Luo H, Zuo G, Ren K, Wan Y. Novel porous graphene oxide and hydroxyapatite nanosheets-reinforced sodium alginate hybrid nanocomposites for medical applications. Materials Characterization. 2015;107:419–25. https://doi.org/10.1016/j.matchar.2015.07.016.
Saravanan S, Chawla A, Vairamani M, Sastry TP, Subramanian KS, Selvamurugan N. Scaffolds containing chitosan, gelatin and graphene oxide for bone tissue regeneration in vitro and in vivo. Int J Biol Macromol. 2017;104:1975–85. https://doi.org/10.1016/j.ijbiomac.2017.01.034.
Fayyazbakhsh F, Solati-Hashjin M, Shokrgozar MA, Bonakdar S, Ganji Y, Mirjordavi N, Ghavimi SA, Khashayar P. Biological evaluation of a novel tissue engineering scaffold of layered double hydroxides (LDHs). InKey Engineering Materials. 2012;494:902–8. https://doi.org/10.4028/www.scientific.net/KEM.493-494.902.
JR Jameson. Characterization of bone material properties and microstructure in osteogenesis imperfecta/brittle bone disease. 2009. http://epublications.marquette.edu/dissertations_mu/413.
Liao KH, Lin YS, MacOsko CW, Haynes CL. Cytotoxicity of graphene oxide and graphene in human erythrocytes and skin fibroblasts. ACS Appl Mater Interfaces. 2011;3:2607–15. https://doi.org/10.1021/am200428v.
Ma J, Liu R, Wang X, Liu Q, Chen Y, Valle RP, et al. Crucial role of lateral size for graphene oxide in activating macrophages and stimulating pro-inflammatory responses in cells and animals. ACS Nano. 2015;9:10498–515. https://doi.org/10.1021/acsnano.5b04751.
Zhang X, Yin J, Peng C, Hu W, Zhu Z, Li W, et al. Distribution and biocompatibility studies of graphene oxide in mice after intravenous administration. Carbon N Y. 2011;49:986–95. https://doi.org/10.1016/j.carbon.2010.11.005.
Bajpai AK, Choubey J. Design of gelatin nanoparticles as swelling controlled delivery system for chloroquine phosphate. J Mater Sci Mater Med. 2006;17:345–58. https://doi.org/10.1007/s10856-006-8235-9.
Kokubo T, Kushitani H, Sakka S, Kitsugi T, Yamamuro T. Solutions able to reproduce in vivo surface‐structure changes in bioactive glass‐ceramic A‐W3. J Biomed Mater Res. 1990;24:721–34. https://doi.org/10.1002/jbm.820240607.
Belgheisi G, Nazarpak MH, Hashjin MS. Bone tissue engineering electrospun scaffolds based on layered double hydroxides with the ability to release vitamin D3: fabrication, characterization and in vitro study. Appl Clay Sci. 2020;185:105434. https://doi.org/10.1016/j.clay.2019.105434.
Keselowsky BG, Collard DM, García AJ. Surface chemistry modulates focal adhesion composition and signaling through changes in integrin binding. Biomaterials. 2004;25:5947–54. https://doi.org/10.1016/j.biomaterials.2004.01.062.
Lord MS, Foss M, Besenbacher F. Influence of nanoscale surface topography on protein adsorption and cellular response. Nano Today. 2010;5:66–78. https://doi.org/10.1016/j.nantod.2010.01.001.
Vogler EA. Structure and reactivity of water at biomaterial surfaces. Adv Colloid Interface Sci. 1998;74:69–117. https://doi.org/10.1016/S0001-8686(97)00040-7.
Štefková K, Procházková J, Pacherník J. Alkaline phosphatase in stem cells. Stem Cells Int. 2015;2015. https://doi.org/10.1155/2015/628368.
Purohit SD, Bhaskar R, Singh H, Yadav I, Gupta MK, Mishra NC. Development of a nanocomposite scaffold of gelatin–alginate–graphene oxide for bone tissue engineering. Int J Biol Macromol. 2019;133:592–602. https://doi.org/10.1016/j.ijbiomac.2019.04.113.
Nair M, Nancy D, Krishnan AG, Anjusree GS, Vadukumpully S, Nair SV. Graphene oxide nanoflakes incorporated gelatin-hydroxyapatite scaffolds enhance osteogenic differentiation of human mesenchymal stem cells. Nanotechnology. 2015;26:161001. https://doi.org/10.1088/0957-4484/26/16/161001.
Dvorak MM, Riccardi D. Ca2+ as an extracellular signal in bone. Cell Calcium. 2004;35:249–55. https://doi.org/10.1016/j.ceca.2003.10.014.
Sugimoto T, Kanatani M, Kano J, Kaji H, Tsukamoto T, Yamaguchi T, et al. Effects of high calcium concentration on the functions and interactions of osteoblastic cells and monocytes and on the formation of osteoclast‐like cells. J Bone Miner Res. 1993;8:1445–52. https://doi.org/10.1002/jbmr.5650081206.
Majeska R, Rodan GA. The effect of 1,25(OH)2D3 on alkaline phosphatase in osteoblastic osteosarcoma cells. J Biol Chem. 1982;257:3362–5.
Dong SW, Ying DJ, Duan XJ, Xie Z, Yu ZJ, Zhu CH, et al. Bone regeneration using an acellular extracellular matrix and bone marrow mesenchymal stem cells expressing Cbfal. Biosci Biotechnol Biochem. 2009;73:2226–33. https://doi.org/10.1271/bbb.90329.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Mahdavi, R., Belgheisi, G., Haghbin-Nazarpak, M. et al. Bone tissue engineering gelatin–hydroxyapatite/graphene oxide scaffolds with the ability to release vitamin D: fabrication, characterization, and in vitro study. J Mater Sci: Mater Med 31, 97 (2020). https://doi.org/10.1007/s10856-020-06430-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10856-020-06430-5